Ebola vaccine trials start in Ituri
The Democratic Republic of the Congo has launched a clinical trial for a vaccine against the Ebola epidemic in the city of Bunia, Ituri Province, amid an outbreak that has resulted in over 3,600 deaths and approximately 7,500 infections since the outbreak began in May. The trial involves 20,000 participants and aims to assess the effectiveness of the "Ervebo" vaccine against the common "Zaire" strain and to provide protection against the new "Bundibugyo" strain responsible for the current outbreak, which currently has no specific treatment or vaccine. This initiative is considered a significant step in confronting what is being described as the largest and most dangerous Ebola outbreak in the country's history, with the virus continuing to spread across seven provinces.
Notice: This Is an AI-Generated Summary
Comments (0)